DUBLIN, Mar 6, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Respiratory Care Device Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.
The global respiratory diagnostic and monitoring device market was valued at $4,348.1 million in 2015, and it is expected to grow at a CAGR of 8.1% during 2016 - 2022. The technological advancement in respiratory monitoring and diagnosis devices, increasing prevalence of respiratory diseases, growing geriatric population and high prevalence of tobacco smoking are the key factors driving the growth of the global market.
Respiratory diseases are diseases that affect human respiration. Asthma, chronic obstructive pulmonary disease, chronic bronchitis, pulmonary edema, lung cancer, emphysema and cystic fibrosis are some of the major respiratory diseases. The chronic obstructive pulmonary disease is a major health problem which causes morbidity and mortality. According to the WHO Global Status Report on NCDs 2010, smoking is estimated to cause about 71% of all lung cancer deaths and 42% of chronic respiratory disease worldwide. In addition, according to National Heart, Lung and Blood Institute, approximately 235,000 deaths in 2010 were caused due to lung diseases, excluding lung cancer.
Among the different end user of respiratory diagnostic and monitoring device, the home care market would witness fastest growth during the forecast period. Growing geriatric population and increasing demand for home care are the major factors driving the growth of the respiratory diagnostic and monitoring device in home care market.
North America accounted for the largest share in the global market in 2015 and it is expected to grow at the considerable rate during the forecast period. The factors driving the respiratory diagnostic and monitoring device market in the region are growing geriatric population, increasing prevalence of respiratory disease, and high adoption of technologically advanced respiratory diagnostic and monitoring devices. Europe was the second largest market for respiratory diagnostic and monitoring device in 2015. The European market is primarily driven by rapid urbanization, technological advancement of devices, increasing prevalence of respiratory diseases, increasing healthcare expenditure, and high pollution level.
- V. Guldmann A/S
- Handicare Group Ab
- Joerns Healthcare Llc.
- Joh. Stiegelmeyer Gmbh & Co. Kg
- Etac Ab
- Hill-Rom Holdings, Inc.
- Getinge Group
- Invacare Corporation
- Stryker Corporation
- Linet Spol. S.R.O.
Key Topics Covered:
1. Research Scope And Methodology
2. Executive Summary
3. Market Outlook
4. Global Patient Handling Equipment Market Size And Forecast (2012-2022)
5. Global Patient Handling Equipment Market, By Product
6. Global Patient Handling Equipment Market, By Type Of Care
7. Global Patient Handling Equipment Market, By End User
8. Global Patient Handling Equipment Market, By Geography
9. Competitive Analysis
10. Company Profiles And Strategic Developments
For more information about this report visit http://www.researchandmarkets.com/research/8kwqfl/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-respiratory-care-device-market-to-grow-at-a-cagr-of-81-by-2022---by-product-type-of-care-end-user--geography---research-and-markets-300418269.html
SOURCE Research and Markets